Press Release

Jul, 04 2023

Transforming Precision and Efficiency in Laboratory Operations

The growing healthcare demand globally has intensified the competition among leading healthcare and pharmaceutical companies to enhance lab automation. This has led to increased utilization of equipment, analyzers, and software in laboratories. Market players are focusing on offering a wide range of tools, equipment, machines, and techniques to support the development and manufacturing of automated laboratory infrastructure. In order to achieve this, companies are making significant investments and securing funding to develop advanced technologies and methods for lab automation.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-lab-automation-market

Data Bridge Market Research analyses that The Lab Automation Market is growing with a CAGR of 6.6% in the forecast period of 2022 to 2029 and is expected to reach USD 14,275.41 million by 2029. The need for faster and more efficient laboratory processes, particularly in drug discovery and clinical diagnostics, is driving the adoption of lab automation solutions. High-throughput screening capabilities offered by automated systems enable researchers to analyze large volumes of samples in a shorter time, accelerating research and development processes.

Key Findings of the Study      

Lab Automation Market

Cost and time savings are expected to drive the market's growth rate

Lab automation offers substantial cost and time savings by reducing manual labor and streamlining workflows. Automated systems handle sample preparation, data analysis, and report generation efficiently, freeing up researchers' time for more valuable tasks. The elimination of repetitive and time-consuming manual processes not only improves productivity but also reduces the risk of human errors. These cost and time savings make lab automation an attractive solution for industries seeking efficiency, accuracy, and improved research and development outcomes.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014-2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Equipment, Software and Informatics and Analyzer), Automation Type (Modular Automation and Total Lab automation), Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions, Bio Analysis, Protein Engineering, Lyophilization, System Biology, Analytical Chemistry and Others), End Users (Biotechnology and Pharmaceuticals, Hospitals and Laboratories, Research and Academic Institutions and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

QIAGEN (Germany), Siemens Healthcare (Germany),F. Hoffmann-La Roche Ltd (Roche) (Switzerland), Hamilton Company (U.S.), Hudson Robotics (U.S.),LabVantage Solutions Inc. (U.S.),Abbott (U.S.),BD (Becton, Dickinson and Company) (U.S.),bioMérieux (France), Aurora Biomed Inc. (Canada), Danaher (U.S.), Tecan Trading AG - Headquarters: Männedorf, SwitzerlandPerkinElmer Inc. (U.S.), Fisher Scientific (U.S.), Agilent Technologies (U.S.), Azenta US Inc. (U.S.),Eppendorf SE (Germany),Labware (U.S.) among others

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The lab automation market is segmented on the basis of product type, automated systems, application and end user.

  • On the basis of product type, the global lab automation market is segmented into equipment, software and informatics, and analyzer. In 2022, the equipment segment is expected to dominate the market with a CAGR of 7.5% in the forecast period of 2022 to 2029 due to being more commonly used as they act as base things in the automated laboratories

 In 2022, the equipment segment is expected to dominate the product type segment of the global lab automation market

In 2022, the equipment segment is expected to dominate the market owing to equipment such as freezing machines, cutting and slicing machines, blanching machines, sorting and grading machines, and packaging machines. These equipment play a crucial role in ensuring efficient and high-quality processing of frozen fruit and vegetable mixes with a CAGR of 7.5% in the forecast period of 2022 to 2029

  • On the basis of automation systems, the global lab automation market is segmented into modular automation and total lab automation. Total lab automation segment is expected to dominate the market with a 67.79% market share in the forecast period of 2022 to 2029 due to type of automation has more impact in the market due to their advanced technologies and novel features
  • On the basis of application, the global lab automation market is segmented into drug discovery, clinical diagnostics, genomic solutions, proteomic solutions, bio analysis, protein engineering, lyophilization, system biology, analytical chemistry, and others. Clinical diagnostics segment is expected to dominate the market with a 28.83% market share in the forecast period of 2022 to 2029 due to this category has more use of automated laboratories to implement the advanced tools, machinery and equipment for the diagnostics.

In 2022, the clinical diagnostics segment is expected to dominate the application segment of the global lab automation market

In 2022, the clinical diagnostics segment is expected to dominate the market with a 28.83% market share owing to quality control samples to ensure the accuracy and precision of diagnostic tests. They can also be used in research studies to investigate the impact of specific compounds or nutrients on health markers in the forecast period of 2022 to 2029

  • On the basis of end users, the global lab automation market is segmented into biotechnology and pharmaceuticals, hospitals and laboratories, research and academic institutions, and others. In 2022, the biotechnology and pharmaceuticals segment is expected to dominate the global lab automation market with a 60.73% market share in the forecast period of 2022 to 2029 due to the regular use of the automated equipment and systems.

Major Players

Data Bridge Market Research recognizes the following companies as the major lab automation market players in lab automation market are QIAGEN (Germany), Siemens Healthcare (Germany),F. Hoffmann-La Roche Ltd (Roche) (Switzerland), Hamilton Company (U.S.), Hudson Robotics (U.S.),LabVantage Solutions Inc. (U.S.),Abbott (U.S.),BD (Becton, Dickinson and Company) (U.S.),bioMérieux (France), Aurora Biomed Inc. (Canada)

Lab Automation Market

Market Development

  • In 2023, Avida Biomed, a startup life science company that develops high-performance target-enrichment techniques with unique features for clinical researchers using next-generation sequencing techniques to study cancer, was acquired by Agilent Technologies.
  • In 2022, BD declared that the acquisition of privately held Straub Medical AG had been completed. With this acquisition, the business has expanded its product line and added the invaluable knowledge and experience of Straub Medical AG.
  • In 2022, In order to offer non-invasive prenatal testing options, QIAGEN announced new collaboration with Atlia Biosystems.
  • In 2022, F. Hoffmann-La Roche Ltd. and PathAI worked together to develop digital pathology applications based on artificial intelligence for better patient care.
  • In 2022, Adeno-associated virus vector (AAV) detection kits that are ready to use have been made available by PerkinElmer to assist gene therapy researchers.
  • In 2021, a fully automated high-throughput molecular diagnostic platform has been made available to laboratories in the US by Becton Dickinson AG.

Regional Analysis

Geographically, the countries covered in the lab automation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

North America is expected to dominate region in the lab automation market during the forecast period 2022-2029

North America dominated the lab automation market and accounted for the largest revenue share of 36.4% in 2020 and is expected to maintain the position during the forecast period. The growth is attributed to the presence of a well-established healthcare infrastructure, which has led to an increase in the adoption of lab automation systems in the region. In addition, the local presence of major players and supportive reimbursement framework in this region is also boosting the penetration of novel solutions in the market.

Asia-Pacific is estimated to be the fastest-growing region in the lab automation market for the forecast period 2022-2029

In Asia Pacific, the market is expected to exhibit an exponential CAGR of 9.9% during the forecast period, which can be attributed to the growing demand for lab automation in emerging economies, such as China and India. The lucrative growth registered by this region is also believed to be an outcome of increasing initiatives by regional and international players to provide accessibility to novel lab automation solutions in these potential markets.

For more detailed information about the lab automation market report, click here – https://www.databridgemarketresearch.com/reports/global-lab-automation-market


Client Testimonials